349 related articles for article (PubMed ID: 23500889)
61. Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.
Panner A; Crane CA; Weng C; Feletti A; Fang S; Parsa AT; Pieper RO
Cancer Res; 2010 Jun; 70(12):5046-53. PubMed ID: 20484045
[TBL] [Abstract][Full Text] [Related]
62. Modulation of the activity of cytosolic phospholipase A2alpha (cPLA2alpha) by cellular sphingolipids and inhibition of cPLA2alpha by sphingomyelin.
Nakamura H; Wakita S; Suganami A; Tamura Y; Hanada K; Murayama T
J Lipid Res; 2010 Apr; 51(4):720-8. PubMed ID: 19965591
[TBL] [Abstract][Full Text] [Related]
63. Telomerase reverse transcriptase induced thyroid carcinoma cell proliferation through PTEN/AKT signaling pathway.
Zhang H; Hu N
Mol Med Rep; 2018 Aug; 18(2):1345-1352. PubMed ID: 29901196
[TBL] [Abstract][Full Text] [Related]
64. PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer.
Zheng Y; Wang Z; Bie W; Brauer PM; Perez White BE; Li J; Nogueira V; Raychaudhuri P; Hay N; Tonetti DA; Macias V; Kajdacsy-Balla A; Tyner AL
Cancer Res; 2013 Sep; 73(17):5426-37. PubMed ID: 23856248
[TBL] [Abstract][Full Text] [Related]
65. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
Shukla S; Bhaskaran N; Babcook MA; Fu P; Maclennan GT; Gupta S
Carcinogenesis; 2014 Feb; 35(2):452-60. PubMed ID: 24067903
[TBL] [Abstract][Full Text] [Related]
66. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.
Hu S; Duan YX; Zhou Q; Wang Y; Lu Q
IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986
[TBL] [Abstract][Full Text] [Related]
67. Methylated urolithin A, the modified ellagitannin-derived metabolite, suppresses cell viability of DU145 human prostate cancer cells via targeting miR-21.
Zhou B; Wang J; Zheng G; Qiu Z
Food Chem Toxicol; 2016 Nov; 97():375-384. PubMed ID: 27725205
[TBL] [Abstract][Full Text] [Related]
68. (‑)‑Epigallocatechin‑3‑gallate induces apoptosis in human pancreatic cancer cells via PTEN.
Liu S; Xu ZL; Sun L; Liu Y; Li CC; Li HM; Zhang W; Li CJ; Qin W
Mol Med Rep; 2016 Jul; 14(1):599-605. PubMed ID: 27176210
[TBL] [Abstract][Full Text] [Related]
69. Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival.
Rokhlin OW; Taghiyev AF; Bayer KU; Bumcrot D; Koteliansk VE; Glover RA; Cohen MB
Cancer Biol Ther; 2007 May; 6(5):732-42. PubMed ID: 17387273
[TBL] [Abstract][Full Text] [Related]
70. Prostate cancer ETS rearrangements switch a cell migration gene expression program from RAS/ERK to PI3K/AKT regulation.
Selvaraj N; Budka JA; Ferris MW; Jerde TJ; Hollenhorst PC
Mol Cancer; 2014 Mar; 13():61. PubMed ID: 24642271
[TBL] [Abstract][Full Text] [Related]
71. Differential role of PTEN in transforming growth factor β (TGF-β) effects on proliferation and migration in prostate cancer cells.
Kimbrough-Allah MN; Millena AC; Khan SA
Prostate; 2018 Apr; 78(5):377-389. PubMed ID: 29341212
[TBL] [Abstract][Full Text] [Related]
72. Phosphatase and Tensin Homolog Is a Potential Target for Ovarian Cancer Sensitization to Cytotoxic Agents.
McCormick A; Earp E; Leeson C; Dixon M; O'Donnell R; Kaufmann A; Edmondson RJ
Int J Gynecol Cancer; 2016 May; 26(4):632-9. PubMed ID: 26905328
[TBL] [Abstract][Full Text] [Related]
73. Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate Cancer.
Yan Y; Huang H
Adv Exp Med Biol; 2019; 1210():319-331. PubMed ID: 31900915
[TBL] [Abstract][Full Text] [Related]
74. Purinergic receptor-mediated rapid depletion of nuclear phosphorylated Akt depends on pleckstrin homology domain leucine-rich repeat phosphatase, calcineurin, protein phosphatase 2A, and PTEN phosphatases.
Mistafa O; Ghalali A; Kadekar S; Högberg J; Stenius U
J Biol Chem; 2010 Sep; 285(36):27900-10. PubMed ID: 20605778
[TBL] [Abstract][Full Text] [Related]
75. Targeting cPLA2α inhibits gastric cancer and augments chemotherapy efficacy via suppressing Ras/MEK/ERK and Akt/β-catenin pathways.
Liao Y; Chen W; Shi W; Zha H
Cancer Chemother Pharmacol; 2021 Oct; 88(4):689-697. PubMed ID: 34255137
[TBL] [Abstract][Full Text] [Related]
76. A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.
Hessenkemper W; Roediger J; Bartsch S; Houtsmuller AB; van Royen ME; Petersen I; Grimm MO; Baniahmad A
Mol Endocrinol; 2014 Nov; 28(11):1831-40. PubMed ID: 25203674
[TBL] [Abstract][Full Text] [Related]
77. The effect and mechanism of CXCR4 silencing on metastasis suppression of human glioma U87 cell line.
Zhu Y; Yang P; Zhang X; Zhang L; Cui G; Wang Q; Lv L; Zhang Y; Xin X; Yan T; Zhao M; Zhang N
Anat Rec (Hoboken); 2013 Dec; 296(12):1857-64. PubMed ID: 24249397
[TBL] [Abstract][Full Text] [Related]
78. Adenoviruses-mediated RNA interference targeting cytosolic phospholipase A2α attenuates focal ischemic brain damage in mice.
Wu H; Liu H; Zuo F; Zhang L
Mol Med Rep; 2018 Apr; 17(4):5601-5610. PubMed ID: 29484397
[TBL] [Abstract][Full Text] [Related]
79. Stromal TGF-β signaling induces AR activation in prostate cancer.
Yang F; Chen Y; Shen T; Guo D; Dakhova O; Ittmann MM; Creighton CJ; Zhang Y; Dang TD; Rowley DR
Oncotarget; 2014 Nov; 5(21):10854-69. PubMed ID: 25333263
[TBL] [Abstract][Full Text] [Related]
80. Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer.
Carver BS; Chapinski C; Wongvipat J; Hieronymus H; Chen Y; Chandarlapaty S; Arora VK; Le C; Koutcher J; Scher H; Scardino PT; Rosen N; Sawyers CL
Cancer Cell; 2011 May; 19(5):575-86. PubMed ID: 21575859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
